Raising orphans: how clinical development programs of drugs for rare and common diseases are different
Clinical Pharmacology & Therapeutics, 07/16/2012

1 Astellas pharma global development announces management reorganization Full Text Astellas, April 3, 2013    Free full text

2 Abbott Initiates Voluntary Recall of FreeStyle InsuLinx Blood Glucose Meters in the United States Full Text Abbott, April 16, 2013    Free full text

3 Warner Chilcott Announces FDA Approval of New Oral Contraceptive Full Text Warner Chilcott, April 25, 2013    Free full text

4 FDA alerts providers to mattress cover safety risks Full Text American Hospital Association News, April 29, 2013    Free full text

5 Statement on FOSAMAX (alendronate sodium) Product Liability Trial Full Text Merck, March 12, 2013    Free full text

6 FDA alerts providers to drug product recalls Full Text American Hospital Association News, March 29, 2013    Free full text

7 Taro Receives FDA Approval For Topicort (desoximetasone) Topical Spray, 0.25% Full Text Taro Pharmaceuticals USA, April 15, 2013    Free full text

8 Alcon announces FDA approval of Simbrinza Suspension, a new beta blocker-free, fixed-combination therapy for glaucoma patients Full Text Novartis, April 22, 2013    Free full text

9 U.S. FDA Approves INVOKANA (Canagliflozin) to Treat Adults with Type 2 Diabetes Full Text Janssen, April 1, 2013    Free full text

10 CryoLife Receives FDA Clearance For Next Generation HeRO Device Full Text CryoLife, April 5, 2013    Free full text

11 US District Court rules one PULMICORT RESPULES (budesonide inhalation suspension) patent invalid and another patent not infringed Full Text AstraZeneca, April 2, 2013    Free full text

12 FDA approves Diclegis for pregnant women experiencing nausea and vomiting Full Text FDA Press Announcements, April 12, 2013    Free full text

13 CEL-SCI Corporation Provides Update on Phase III Clinical Trial Full Text CEL-SCI, April 24, 2013    Free full text

14 Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure Full Text Astellas, April 16, 2013    Free full text

15 Pfizer Issued Warning Letter for Italian Manufacturing Plant Full Text BioPharm International, April 12, 2013    Free full text

16 Valeant Pharmaceuticals Provides Update to Recent Event Full Text Valeant Pharmaceuticals International, April 5, 2013    Free full text

17 Teva-Handok Names Yoo Suk Hong as Chief Executive Officer Full Text Teva Pharmaceutical Industries, April 9, 2013    Free full text

18 Astellas pharma us, inc. names new president Full Text Astellas, April 3, 2013    Free full text

19 Medivation and astellas provide update on prevail Full Text Astellas, April 5, 2013    Free full text

20 Study: Tablets Can Effectively Read EEG Results Full Text Healthcare Informatics, April 5, 2013    Free full text